DK128352B - Analogifremgangsmåde til fremstilling af 9α-fluor-11β-hydroxypregna-1,4-dien-3,20-dion-[17α,16α-d]-oxazolidinoxaziner. - Google Patents

Analogifremgangsmåde til fremstilling af 9α-fluor-11β-hydroxypregna-1,4-dien-3,20-dion-[17α,16α-d]-oxazolidinoxaziner.

Info

Publication number: DK128352B
Authority: DK; Denmark
Prior art keywords: oxazolidinoxazines; hydroxypregna; dione; diene; fluoro
Prior art date: 1968-05-03

Application number

DK569770AA

Other languages

English (en)

Inventor

G Nathansohn

G Winters

Original Assignee

Lepetit Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1968-05-03

Filing date

1970-11-10

Publication date

1974-04-16

1970-11-10 Application filed by Lepetit Spa filed Critical Lepetit Spa

1974-04-16 Publication of DK128352B publication Critical patent/DK128352B/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0036—Nitrogen-containing hetero ring
- C07J71/0057—Nitrogen and oxygen
- C07J71/0068—Nitrogen and oxygen at position 16(17)
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
- C07J41/0011—Unsubstituted amino radicals

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Steroid Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

DK569770AA 1968-05-03 1970-11-10 Analogifremgangsmåde til fremstilling af 9α-fluor-11β-hydroxypregna-1,4-dien-3,20-dion-[17α,16α-d]-oxazolidinoxaziner. DK128352B (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
IT1602968		1968-05-03

Publications (1)

Publication Number	Publication Date
DK128352B true DK128352B (da)	1974-04-16

Family

ID=11148457

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DK224769AA DK124680B (da)	1968-05-03	1969-04-24	Fremgangsmåde til fremstilling af 2'-substituerede steroid-[16α, 17α-d]-oxazoliner af pregnanrækken.
DK569770AA DK128352B (da)	1968-05-03	1970-11-10	Analogifremgangsmåde til fremstilling af 9α-fluor-11β-hydroxypregna-1,4-dien-3,20-dion-[17α,16α-d]-oxazolidinoxaziner.

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
DK224769AA DK124680B (da)	1968-05-03	1969-04-24	Fremgangsmåde til fremstilling af 2'-substituerede steroid-[16α, 17α-d]-oxazoliner af pregnanrækken.

Country Status (16)

Country	Link
US (1)	US3631033A (da)
AT (2)	AT300218B (da)
BE (1)	BE731718A (da)
BR (1)	BR6908511D0 (da)
CH (1)	CH511823A (da)
DE (1)	DE1921778A1 (da)
DK (2)	DK124680B (da)
ES (2)	ES366738A1 (da)
FI (3)	FI46374C (da)
FR (1)	FR2007756B1 (da)
GB (1)	GB1254487A (da)
IL (1)	IL31997A (da)
LU (1)	LU58451A1 (da)
NL (2)	NL6906149A (da)
NO (1)	NO128608B (da)
SE (4)	SE373131B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL7107998A (da) *	1970-07-09	1972-01-11
IT1134455B (it) *	1980-11-26	1986-08-13	Lepetit Spa	Procedimento per la preparazione di derivati 16alfa-idrossi-17alfa-aminopregnanici
US20030083231A1 (en) *	1998-11-24	2003-05-01	Ahlem Clarence N.	Blood cell deficiency treatment method
US20050101581A1 (en) *	2002-08-28	2005-05-12	Reading Christopher L.	Therapeutic treatment methods 2
KR20050057086A (ko) *	2002-08-28	2005-06-16	홀리스-에덴 파마슈티칼즈, 인코포레이티드	치료적 처치 방법
CA2773594C (en) *	2009-09-11	2018-09-25	Chiesi Farmaceutici S.P.A.	Isoxazolidine derivatives
EP2686332A2 (en)	2011-03-15	2014-01-22	Chiesi Farmaceutici S.p.A.	Isoxazolidine derivatives
CA2829982A1 (en) *	2011-03-15	2012-09-20	Chiesi Farmaceutici S.P.A.	Isoxazolidine derivatives
US9155747B2 (en) *	2012-09-13	2015-10-13	Chiesi Farmaceutici S.P.A.	Isoxazolidine derivatives

1969
- 1969-04-11 IL IL31997A patent/IL31997A/xx unknown
- 1969-04-18 LU LU58451D patent/LU58451A1/xx unknown
- 1969-04-18 BE BE731718D patent/BE731718A/xx unknown
- 1969-04-21 NL NL6906149A patent/NL6906149A/xx unknown
- 1969-04-24 DK DK224769AA patent/DK124680B/da unknown
- 1969-04-29 DE DE19691921778 patent/DE1921778A1/de not_active Withdrawn
- 1969-04-30 FR FR6913817A patent/FR2007756B1/fr not_active Expired
- 1969-05-01 US US821149A patent/US3631033A/en not_active Expired - Lifetime
- 1969-05-02 FI FI691290A patent/FI46374C/fi active
- 1969-05-02 SE SE7203865A patent/SE373131B/xx unknown
- 1969-05-02 GB GB22523/69A patent/GB1254487A/en not_active Expired
- 1969-05-02 NO NO01825/69A patent/NO128608B/no unknown
- 1969-05-02 AT AT758070A patent/AT300218B/de not_active IP Right Cessation
- 1969-05-02 AT AT426169A patent/AT291450B/de not_active IP Right Cessation
- 1969-05-02 SE SE7203863A patent/SE378250B/xx unknown
- 1969-05-02 SE SE06253/69A patent/SE363098B/xx unknown
- 1969-05-02 BR BR208511/69A patent/BR6908511D0/pt unknown
- 1969-05-02 SE SE7203864A patent/SE373578B/xx unknown
- 1969-05-02 CH CH673969A patent/CH511823A/fr not_active IP Right Cessation
- 1969-05-03 ES ES366738A patent/ES366738A1/es not_active Expired
- 1969-09-29 ES ES371991A patent/ES371991A1/es not_active Expired
1970
- 1970-11-10 DK DK569770AA patent/DK128352B/da unknown
1971
- 1971-12-29 FI FI713714A patent/FI46376C/fi active
- 1971-12-29 FI FI713715A patent/FI46377C/fi active
1977
- 1977-09-02 NL NL7709675A patent/NL7709675A/xx unknown

Also Published As

Publication number	Publication date
BR6908511D0 (pt)	1973-02-08
DE1965963B2 (de)	1973-02-08
NL7709675A (nl)	1977-12-30
NL6906149A (da)	1969-11-05
IL31997A0 (en)	1969-06-25
SE373578B (sv)	1975-02-10
BE731718A (da)	1969-10-01
NO128608B (da)	1973-12-17
LU58451A1 (da)	1969-07-21
FR2007756B1 (da)	1975-10-10
FI46374B (da)	1972-11-30
FR2007756A1 (da)	1970-01-09
ES371991A1 (es)	1971-12-01
DE1921778A1 (de)	1969-11-20
FI46377B (da)	1972-11-30
DK124680B (da)	1972-11-13
US3631033A (en)	1971-12-28
GB1254487A (en)	1971-11-24
AT291450B (de)	1971-07-12
SE363098B (da)	1974-01-07
FI46376B (da)	1972-11-30
FI46377C (fi)	1973-03-12
IL31997A (en)	1974-03-14
ES366738A1 (es)	1971-03-16
FI46374C (fi)	1973-03-12
AT300218B (de)	1972-07-25
SE378250B (da)	1975-08-25
DE1965963A1 (de)	1970-12-23
SE373131B (da)	1975-01-27
CH511823A (fr)	1971-08-31
FI46376C (fi)	1973-03-12

Similar Documents

Publication	Publication Date	Title
DK129835B (da)	1974-11-25	Analogifremgangsmåde til fremstilling af 2-chlor-6α-fluor-16α-methyl-pregna-1,4-dien-3,20-dioner.
DK126500B (da)	1973-07-23	Analogifremgangsmåde til fremstilling af 11-oxygenerede 9α,21-dihalogen-17α-alkanoyloxy-pregn-4-en-3,20-dioner.
DK129988B (da)	1974-12-09	Fremgangsmåde til fremstilling af 17-monoestere af 17α,21-dihydroxy-20-keto-steroidforbindelser af pregnanrækken.
DK120234B (da)	1971-05-03	Fremgangsmåde til fremstilling af 17α-monocarboxylsyreestere af 11β, 17α, 21-trihydroxysteroider af pregnanrækken.
DK119557B (da)	1971-01-25	Analogifremgangsmåde til fremstilling af 17α-benzoyloxy-9α-fluor-16β-methyl-Δ<1,4>-pregnadien-11β, 21-diol-3,20-dion.
DK128352B (da)	1974-04-16	Analogifremgangsmåde til fremstilling af 9α-fluor-11β-hydroxypregna-1,4-dien-3,20-dion-[17α,16α-d]-oxazolidinoxaziner.
DK129704B (da)	1974-11-11	Fremgangsmåde til fremstilling af 17α-klor-6α-fluor-16α-methylpregna-1,4-dien-3,20-dion-21-oler eller estere deraf.
DK124539B (da)	1972-10-30	Fremgangsmåde til fremstilling af 6-hydroxy-3-keto-Δ<1,4>-steroider af pregnan- eller androstanrækken.
DK114060B (da)	1969-05-27	Fremgangsmåde til fremstilling af terapeutisk virksomme 1,2β-metylensteroider af androstan- eller 9-norandrostanrækken.
DK126647B (da)	1973-08-06	Analogifremgangsmåde til fremstilling af 16α,17α-(substitueret-methylen)-steroider af pregnanrækken.
DK127976B (da)	1974-02-11	Analogifremgangsmåde til fremstilling af 21-poly-β-ethoxyethyl-carbonater af 3,20-dioxo-9α-fluor-11β,17α,21-trihydroxy-16α-methylpregna-1,4-dien.
DK120235B (da)	1971-05-03	Analogifremgangsmåde til fremstilling af 9α, 11β-disubstituerede 6α-fluor-16α-methyl-21-halogen-4-pregnen-3,20-dionderivater.
DK127420B (da)	1973-11-05	Analogifremgangsmåde til fremstilling af 6α-fluor-16α,18-dimethyl-1,4-pregnadien-3,20-dionderivater.
DK127107B (da)	1973-09-24	Fremgangsmåde til fremstilling af 17α-propadienyl-17β-hydroxy-steroider.
DK125644B (da)	1973-03-19	Analogifremgangsmåde til fremstilling af 6-halogenpregna-4,6-dien-3,20-dion-[17α, 16α-d]-oxazoliner.
DK127924B (da)	1974-02-04	Analogifremgangsmåde til fremstilling af 7α-methyl-3,16α,17β-trihydroxy-Δ1,3,5(10)-estratrien.
DK130646B (da)	1975-03-17	Analogifremgangsmåde til fremstilling af 17- og/eller 21-alkanoyloxy-11beta-klor-16beta-metylpregna-1,4-dien-3,20-dioner.
DK132226B (da)	1975-11-10	Fremgangsmåde til fremstilling af 16alfa, 17alfa-dialkylsteroider af pregnanrækken.
DK132121B (da)	1975-10-27	Fremgangsmåde til fremstilling af 17alfa-hydroxypregna-4,9(11)-dien-3,20-dion.
DK120487B (da)	1971-06-07	Fremgangsmåde til fremstilling af ætynylderivater af oxosteroider af pregnan-, østran- eller androstanrækken.
DK122453B (da)	1972-03-06	Analogifremgangsmåde til fremstilling af 21-estere af 6α,9α-dihalogen-16α-methyl-Δ<1,4>-pregnadien-11β,21-diol-3,20-dioner.
DK113639B (da)	1969-04-14	Analogifremgangsmåde til fremstilling af 9α-flour-11β-hydroxypregna-1,4-dien-[17α,16α-d]-oxazolin-3,20-dioner.
DK129452B (da)	1974-10-14	Analogifremgangsmåde til fremstilling af 9α-fluor-11β,21-dihydroxy-pregna-1,4-dien-3,20-dion-[17α,16α-d]-oxazolidiner eller oxazolidinooxaziner.
DK128897B (da)	1974-07-22	Analogifremgangsmåde til fremstilling af 2,9α,-11β-trichlor-6α-fluor-16α-methyl-Δ<1,4>-pregnadien-17α,21-diol-3,20-dion eller estere deraf.
DK118237B (da)	1970-07-27	Analogifremgangsmåde til fremstilling af 17α, 21-diestere af 9α, 11β-dichloro-16α-methyl-1,4-pregnadien-17α, 21-diol-3, 20-dion.